| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |